U.S. CAR T-Cell therapy Market Thumbnail Image

2023

U.S. CAR T-Cell therapy Market

U.S. CAR T-Cell therapy Market, by Drug type (Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Others), by Indication (Lymphoma, Acute Lymphocytic Leukemia, Others), by End user (Hospitals, Cancer Treatment Centers): Opportunity Analysis and Industry Forecast, 2021-2031

LS : Pharmaceuticals

  • Aug 2023

  • Pages: 77

  • Tables: 53

  • Charts: 49

Select an option
Cloud Access (30% Off) $2,355 $1,649
Business User License (30% Off) $3,570 $2,499
Enterprise License (30% Off) $5,550 $3,885
Library Membership (15% Off) $1,175 $999
Request Free Sample
Author's: Swapna Singh | Eswara Prasad
Publish Date:
Enquire Before Buying Update on Demand